Pulmocide will present biological profile of First-in-Class inhaled anti-RSV agent, PC786 on upcoming XVIII International Symposium on Respiratory Viral Infections in Lisbon held March 31st – April 2nd 2016.

http://www.themacraefoundation.org/symposium-2016/program/